ReP USP - Resultado da busca

Artigo de periodico
No implication of HIV coinfection on the plasma exposure to rifampicin, pyrazinamide, and ethambutol in tuberculosis patients (2022)
Nardotto, Glauco Henrique Balthazar ; Bollela, Valdes Roberto; Rocha, Adriana; Della Pasqua, Oscar; Lanchote, Vera Lucia
Source: Clinical and Translational Science. Unidades: FMRP, FCFRP
Subjects: HIV, FARMACOCINÉTICA, TUBERCULOSE, ESTUDOS PROSPECTIVOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NARDOTTO, Glauco Henrique Balthazar; BOLLELA, Valdes Roberto; ROCHA, Adriana; DELLA PASQUA, Oscar; LANCHOTE, Vera Lucia. No implication of HIV coinfection on the plasma exposure to rifampicin, pyrazinamide, and ethambutol in tuberculosis patients. Clinical and Translational Science, Malden, 2022. Disponível em: < https://doi.org/10.1111/cts.13169 > DOI: 10.1111/cts.13169.
APA
Nardotto, G. H. B., Bollela, V. R., Rocha, A., Della Pasqua, O., & Lanchote, V. L. (2022). No implication of HIV coinfection on the plasma exposure to rifampicin, pyrazinamide, and ethambutol in tuberculosis patients. Clinical and Translational Science. doi:10.1111/cts.13169
NLM
Nardotto GHB, Bollela VR, Rocha A, Della Pasqua O, Lanchote VL. No implication of HIV coinfection on the plasma exposure to rifampicin, pyrazinamide, and ethambutol in tuberculosis patients [Internet]. Clinical and Translational Science. 2022 ;Available from: https://doi.org/10.1111/cts.13169
Vancouver
Nardotto GHB, Bollela VR, Rocha A, Della Pasqua O, Lanchote VL. No implication of HIV coinfection on the plasma exposure to rifampicin, pyrazinamide, and ethambutol in tuberculosis patients [Internet]. Clinical and Translational Science. 2022 ;Available from: https://doi.org/10.1111/cts.13169
Parte de monografia/livro
Controle terapêutico (2021)
Santos, Silvia Regina Cavani Jorge ; Lanchote, Vera Lucia ; Silva Filho, Carlos Roberto da; Moreira, Fernanda de Lima ; Vianna, Karina Brandt; Camargo, Thais Vieira de ; Souza, Vanessa Kasubeck de ; Messiano, Claudia Garcia; Morales Júnior, Ronaldo
Source: Fundamentos de Toxicologia. Unidades: FCF, FCFRP
Subject: FARMÁCIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Silvia Regina Cavani Jorge; LANCHOTE, Vera Lucia; SILVA FILHO, Carlos Roberto da; et al. Controle terapêutico. In: Fundamentos de Toxicologia[S.l: s.n.], 2021.
APA
Santos, S. R. C. J., Lanchote, V. L., Silva Filho, C. R. da, Moreira, F. de L., Vianna, K. B., Camargo, T. V. de, et al. (2021). Controle terapêutico. In Fundamentos de Toxicologia. São Paulo: Atheneu.
NLM
Santos SRCJ, Lanchote VL, Silva Filho CR da, Moreira F de L, Vianna KB, Camargo TV de, Souza VK de, Messiano CG, Morales Júnior R. Controle terapêutico. In: Fundamentos de Toxicologia. São Paulo: Atheneu; 2021.
Vancouver
Santos SRCJ, Lanchote VL, Silva Filho CR da, Moreira F de L, Vianna KB, Camargo TV de, Souza VK de, Messiano CG, Morales Júnior R. Controle terapêutico. In: Fundamentos de Toxicologia. São Paulo: Atheneu; 2021.
Artigo de periodico
Nifedipine does not alter the pharmacokinetics of venlafaxine enantiomers in healthy subjects phenotyped for CYP2D6, CYP2C19, and CYP3A (2021)
Tozatto, Eduardo; Benzi, Jhohann Richard de Lima ; Rocha, Adriana; Coelho, Eduardo Barbosa ; Lanchote, Vera Lucia
Source: The Journal of Clinical Pharmacology. Unidades: FCFRP, FMRP
Subjects: FÁRMACOS, HIPERTENSÃO, FARMACOCINÉTICA, ANTIDEPRESSIVOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TOZATTO, Eduardo; BENZI, Jhohann Richard de Lima; ROCHA, Adriana; COELHO, Eduardo Barbosa; LANCHOTE, Vera Lucia. Nifedipine does not alter the pharmacokinetics of venlafaxine enantiomers in healthy subjects phenotyped for CYP2D6, CYP2C19, and CYP3A. The Journal of Clinical Pharmacology, Hoboken, v. 61, n. 3, p. 319-327, 2021. Disponível em: < https://doi.org/10.1002/jcph.1745 > DOI: 10.1002/jcph.1745.
APA
Tozatto, E., Benzi, J. R. de L., Rocha, A., Coelho, E. B., & Lanchote, V. L. (2021). Nifedipine does not alter the pharmacokinetics of venlafaxine enantiomers in healthy subjects phenotyped for CYP2D6, CYP2C19, and CYP3A. The Journal of Clinical Pharmacology, 61( 3), 319-327. doi:10.1002/jcph.1745
NLM
Tozatto E, Benzi JR de L, Rocha A, Coelho EB, Lanchote VL. Nifedipine does not alter the pharmacokinetics of venlafaxine enantiomers in healthy subjects phenotyped for CYP2D6, CYP2C19, and CYP3A [Internet]. The Journal of Clinical Pharmacology. 2021 ; 61( 3): 319-327.Available from: https://doi.org/10.1002/jcph.1745
Vancouver
Tozatto E, Benzi JR de L, Rocha A, Coelho EB, Lanchote VL. Nifedipine does not alter the pharmacokinetics of venlafaxine enantiomers in healthy subjects phenotyped for CYP2D6, CYP2C19, and CYP3A [Internet]. The Journal of Clinical Pharmacology. 2021 ; 61( 3): 319-327.Available from: https://doi.org/10.1002/jcph.1745
Artigo de periodico
PK/PD approach to evaluate Meropenem effectiveness in critically ill burn adolescents versus young adults undergoing therapy of septic shock (2021)
Camargo, Thais Vieira de; Silva Júnior, João Manoel da; Silva Junior, Elson Mendes da; Santos, Verônica Jorge; Rocha, Adriana; Lanchote, Vera Lucia ; Santos, Silvia Regina Cavani Jorge ; Gomez, David de Souza
Source: Brazilian Journal of Health Review. Unidades: FM, FCFRP, FCF
Subjects: FARMACOCINÉTICA, FARMACODINÂMICA, CHOQUE SÉPTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CAMARGO, Thais Vieira de; SILVA JÚNIOR, João Manoel da; SILVA JUNIOR, Elson Mendes da; et al. PK/PD approach to evaluate Meropenem effectiveness in critically ill burn adolescents versus young adults undergoing therapy of septic shock. Brazilian Journal of Health Review, Curitiba, v. 4, n. 1, p. 1213-1232, 2021. Disponível em: < http://dx.doi.org/10.34119/bjhrv4n1-107 > DOI: 10.34119/bjhrv4n1-107.
APA
Camargo, T. V. de, Silva Júnior, J. M. da, Silva Junior, E. M. da, Santos, V. J., Rocha, A., Lanchote, V. L., et al. (2021). PK/PD approach to evaluate Meropenem effectiveness in critically ill burn adolescents versus young adults undergoing therapy of septic shock. Brazilian Journal of Health Review, 4( 1), 1213-1232. doi:10.34119/bjhrv4n1-107
NLM
Camargo TV de, Silva Júnior JM da, Silva Junior EM da, Santos VJ, Rocha A, Lanchote VL, Santos SRCJ, Gomez D de S. PK/PD approach to evaluate Meropenem effectiveness in critically ill burn adolescents versus young adults undergoing therapy of septic shock [Internet]. Brazilian Journal of Health Review. 2021 ; 4( 1): 1213-1232.Available from: http://dx.doi.org/10.34119/bjhrv4n1-107
Vancouver
Camargo TV de, Silva Júnior JM da, Silva Junior EM da, Santos VJ, Rocha A, Lanchote VL, Santos SRCJ, Gomez D de S. PK/PD approach to evaluate Meropenem effectiveness in critically ill burn adolescents versus young adults undergoing therapy of septic shock [Internet]. Brazilian Journal of Health Review. 2021 ; 4( 1): 1213-1232.Available from: http://dx.doi.org/10.34119/bjhrv4n1-107
Artigo de periodico
Impact of Plasmodium vivax malaria and antimalarial treatment on cytochrome P450 activity in Brazilian patients (2021)
Almeida, Anne Cristine; Elias, Anna Beatriz Ribeiro; Marques, Maria Paula ; Melo, Gisely Cardoso; Costa, Allyson Guimarães; Figueiredo, Erick Frota Gomes; Brasil, Larissa Wanderley; Rodrigues-Soares, Fernanda; Monteiro, Wuelton Marcelo; Lacerda, Marcus Vinícius Guimarães de; Lanchote, Vera Lucia ; Suarez-Kurtz, Guilherme
Source: British Journal of Clinical Pharmacology. Unidade: FCFRP
Subjects: MALÁRIA, PLASMODIUM, CITOCINAS, DOENÇA AGUDA, QUIMIOTERAPIA, PACIENTES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ALMEIDA, Anne Cristine; ELIAS, Anna Beatriz Ribeiro; MARQUES, Maria Paula; et al. Impact of Plasmodium vivax malaria and antimalarial treatment on cytochrome P450 activity in Brazilian patients. British Journal of Clinical Pharmacology, Chichester, v. 87, n. 4, p. 1859-1868, 2021. Disponível em: < https://doi.org/10.1111/bcp.14574 > DOI: 10.1111/bcp.14574.
APA
Almeida, A. C., Elias, A. B. R., Marques, M. P., Melo, G. C., Costa, A. G., Figueiredo, E. F. G., et al. (2021). Impact of Plasmodium vivax malaria and antimalarial treatment on cytochrome P450 activity in Brazilian patients. British Journal of Clinical Pharmacology, 87( 4), 1859-1868. doi:10.1111/bcp.14574
NLM
Almeida AC, Elias ABR, Marques MP, Melo GC, Costa AG, Figueiredo EFG, Brasil LW, Rodrigues-Soares F, Monteiro WM, Lacerda MVG de, Lanchote VL, Suarez-Kurtz G. Impact of Plasmodium vivax malaria and antimalarial treatment on cytochrome P450 activity in Brazilian patients [Internet]. British Journal of Clinical Pharmacology. 2021 ; 87( 4): 1859-1868.Available from: https://doi.org/10.1111/bcp.14574
Vancouver
Almeida AC, Elias ABR, Marques MP, Melo GC, Costa AG, Figueiredo EFG, Brasil LW, Rodrigues-Soares F, Monteiro WM, Lacerda MVG de, Lanchote VL, Suarez-Kurtz G. Impact of Plasmodium vivax malaria and antimalarial treatment on cytochrome P450 activity in Brazilian patients [Internet]. British Journal of Clinical Pharmacology. 2021 ; 87( 4): 1859-1868.Available from: https://doi.org/10.1111/bcp.14574
Artigo de periodico
Effect of lercanidipine on the pharmacokinetics-pharmacodynamics of carvedilol enantiomers in patients with chronic kidney disease (2020)
Schaab, Estela Hanauer; Lanchote, Vera Lucia ; Nardotto, Glauco Henrique Balthazar ; Pereira, Maria Paula Marques ; Dantas, Márcio ; Paiva, Carlos Eduardo; Coelho, Eduardo Barbosa
Source: The Journal of Clinical Pharmacology. Unidades: FCFRP, FMRP
Subjects: NEFROPATIAS, INTERAÇÃO ENTRE ALIMENTOS E MEDICAMENTOS, FARMACOCINÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SCHAAB, Estela Hanauer; LANCHOTE, Vera Lucia; NARDOTTO, Glauco Henrique Balthazar; et al. Effect of lercanidipine on the pharmacokinetics-pharmacodynamics of carvedilol enantiomers in patients with chronic kidney disease. The Journal of Clinical Pharmacology, Hoboken, v. 60, n. 1, p. 75-85, 2020. Disponível em: < https://doi.org/10.1002/jcph.1485 > DOI: 10.1002/jcph.1485.
APA
Schaab, E. H., Lanchote, V. L., Nardotto, G. H. B., Pereira, M. P. M., Dantas, M., Paiva, C. E., & Coelho, E. B. (2020). Effect of lercanidipine on the pharmacokinetics-pharmacodynamics of carvedilol enantiomers in patients with chronic kidney disease. The Journal of Clinical Pharmacology, 60( 1), 75-85. doi:10.1002/jcph.1485
NLM
Schaab EH, Lanchote VL, Nardotto GHB, Pereira MPM, Dantas M, Paiva CE, Coelho EB. Effect of lercanidipine on the pharmacokinetics-pharmacodynamics of carvedilol enantiomers in patients with chronic kidney disease [Internet]. The Journal of Clinical Pharmacology. 2020 ; 60( 1): 75-85.Available from: https://doi.org/10.1002/jcph.1485
Vancouver
Schaab EH, Lanchote VL, Nardotto GHB, Pereira MPM, Dantas M, Paiva CE, Coelho EB. Effect of lercanidipine on the pharmacokinetics-pharmacodynamics of carvedilol enantiomers in patients with chronic kidney disease [Internet]. The Journal of Clinical Pharmacology. 2020 ; 60( 1): 75-85.Available from: https://doi.org/10.1002/jcph.1485
Artigo de periodico-carta/editorial
Nonrelevant pharmacokinetic drug-drug interaction between furosemide and pindolol enantiomers in hypertensive parturient women [Carta] (2020)
Gonçalves, Paulo Vinícius Bernardes; Moreira, Fernanda de Lima; Benzi, Jhohann Richard de Lima ; Cavalli, Ricardo de Carvalho; Duarte, Geraldo; Lanchote, Vera Lucia
Source: The Journal of Clinical Pharmacology. Unidades: FCFRP, FMRP
Subjects: FARMACOCINÉTICA, TRABALHO DE PARTO INDUZIDO, HIPERTENSÃO NA GRAVIDEZ
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GONÇALVES, Paulo Vinícius Bernardes; MOREIRA, Fernanda de Lima; BENZI, Jhohann Richard de Lima; et al. Nonrelevant pharmacokinetic drug-drug interaction between furosemide and pindolol enantiomers in hypertensive parturient women [Carta]. The Journal of Clinical Pharmacology[S.l: s.n.], 2020.Disponível em: DOI: 10.1002/jcph.1719.
APA
Gonçalves, P. V. B., Moreira, F. de L., Benzi, J. R. de L., Cavalli, R. de C., Duarte, G., & Lanchote, V. L. (2020). Nonrelevant pharmacokinetic drug-drug interaction between furosemide and pindolol enantiomers in hypertensive parturient women [Carta]. The Journal of Clinical Pharmacology. Hoboken. doi:10.1002/jcph.1719
NLM
Gonçalves PVB, Moreira F de L, Benzi JR de L, Cavalli R de C, Duarte G, Lanchote VL. Nonrelevant pharmacokinetic drug-drug interaction between furosemide and pindolol enantiomers in hypertensive parturient women [Carta] [Internet]. The Journal of Clinical Pharmacology. 2020 ; 60( 11): 1527-1529.Available from: https://doi.org/10.1002/jcph.1719
Vancouver
Gonçalves PVB, Moreira F de L, Benzi JR de L, Cavalli R de C, Duarte G, Lanchote VL. Nonrelevant pharmacokinetic drug-drug interaction between furosemide and pindolol enantiomers in hypertensive parturient women [Carta] [Internet]. The Journal of Clinical Pharmacology. 2020 ; 60( 11): 1527-1529.Available from: https://doi.org/10.1002/jcph.1719
Artigo de periodico
Total, renal and hepatic clearances of doxorubicin and formation clearance of doxorubicinol in patients with breast cancer: estimation of doxorubicin hepatic extraction ratio (2020)
Pippa, Leandro Francisco ; Oliveira, Milena Locci de ; Rocha, Adriana; Andrade, Jurandyr Moreira de ; Lanchote, Vera Lucia
Source: Journal of Pharmaceutical and Biomedical Analysis. Unidades: FCFRP, FMRP
Subjects: ANTINEOPLÁSICOS, FARMACOCINÉTICA, VARIAÇÃO (BIOLOGIA), NEOPLASIAS MAMÁRIAS, MIOCARDIOPATIA CONGESTIVA, QUIMIOTERAPIA, CROMATOGRAFIA LÍQUIDA DE ALTA PRESSÃO, ESPECTROMETRIA DE MASSAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PIPPA, Leandro Francisco; OLIVEIRA, Milena Locci de; ROCHA, Adriana; ANDRADE, Jurandyr Moreira de; LANCHOTE, Vera Lucia. Total, renal and hepatic clearances of doxorubicin and formation clearance of doxorubicinol in patients with breast cancer: estimation of doxorubicin hepatic extraction ratio. Journal of Pharmaceutical and Biomedical Analysis, Amsterdam, v. 185, 2020. Disponível em: < https://doi.org/10.1016/j.jpba.2020.113231 > DOI: 10.1016/j.jpba.2020.113231.
APA
Pippa, L. F., Oliveira, M. L. de, Rocha, A., Andrade, J. M. de, & Lanchote, V. L. (2020). Total, renal and hepatic clearances of doxorubicin and formation clearance of doxorubicinol in patients with breast cancer: estimation of doxorubicin hepatic extraction ratio. Journal of Pharmaceutical and Biomedical Analysis, 185. doi:10.1016/j.jpba.2020.113231
NLM
Pippa LF, Oliveira ML de, Rocha A, Andrade JM de, Lanchote VL. Total, renal and hepatic clearances of doxorubicin and formation clearance of doxorubicinol in patients with breast cancer: estimation of doxorubicin hepatic extraction ratio [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2020 ; 185Available from: https://doi.org/10.1016/j.jpba.2020.113231
Vancouver
Pippa LF, Oliveira ML de, Rocha A, Andrade JM de, Lanchote VL. Total, renal and hepatic clearances of doxorubicin and formation clearance of doxorubicinol in patients with breast cancer: estimation of doxorubicin hepatic extraction ratio [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2020 ; 185Available from: https://doi.org/10.1016/j.jpba.2020.113231
Artigo de periodico
Direct chiral LC-MS/MS analysis of fexofenadine enantiomers in plasma and urine with application in a maternal-fetal pharmacokinetic study (2020)
Pinto, Leonardo Santos Ribeiro; Vale, Gabriel Tavares do ; Moreira, Fernanda de Lima ; Pereira, Maria Paula Marques ; Coelho, Eduardo Barbosa ; Cavalli, Ricardo de Carvalho ; Lanchote, Vera Lucia
Source: Journal of Chromatography B. Unidades: FCFRP, FMRP, EERP
Subjects: ESPECTROMETRIA DE MASSAS, ANTI-HISTAMÍNICOS, FARMACOCINÉTICA, CROMATOGRAFIA LÍQUIDA DE ALTA PRESSÃO, PLASMA, GRAVIDEZ
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PINTO, Leonardo Santos Ribeiro; VALE, Gabriel Tavares do; MOREIRA, Fernanda de Lima; et al. Direct chiral LC-MS/MS analysis of fexofenadine enantiomers in plasma and urine with application in a maternal-fetal pharmacokinetic study. Journal of Chromatography B, Amsterdam, v. 1145, 2020. Disponível em: < https://doi.org/10.1016/j.jchromb.2020.122094 > DOI: 10.1016/j.jchromb.2020.122094.
APA
Pinto, L. S. R., Vale, G. T. do, Moreira, F. de L., Pereira, M. P. M., Coelho, E. B., Cavalli, R. de C., & Lanchote, V. L. (2020). Direct chiral LC-MS/MS analysis of fexofenadine enantiomers in plasma and urine with application in a maternal-fetal pharmacokinetic study. Journal of Chromatography B, 1145. doi:10.1016/j.jchromb.2020.122094
NLM
Pinto LSR, Vale GT do, Moreira F de L, Pereira MPM, Coelho EB, Cavalli R de C, Lanchote VL. Direct chiral LC-MS/MS analysis of fexofenadine enantiomers in plasma and urine with application in a maternal-fetal pharmacokinetic study [Internet]. Journal of Chromatography B. 2020 ; 1145Available from: https://doi.org/10.1016/j.jchromb.2020.122094
Vancouver
Pinto LSR, Vale GT do, Moreira F de L, Pereira MPM, Coelho EB, Cavalli R de C, Lanchote VL. Direct chiral LC-MS/MS analysis of fexofenadine enantiomers in plasma and urine with application in a maternal-fetal pharmacokinetic study [Internet]. Journal of Chromatography B. 2020 ; 1145Available from: https://doi.org/10.1016/j.jchromb.2020.122094
Artigo de periodico
Limited sampling modeling for estimation of phenotypic metrics for CYP enzymes and the ABCB1 transporter using a cocktail approach (2020)
Coelho, Eduardo Barbosa ; Cusinato, Diego Alberto Ciscato ; Ximenez, João Paulo Bianchi ; Lanchote, Vera Lucia ; Struchiner, Claudio José; Suarez-Kurtz, Guilherme
Source: Frontiers in Pharmacology. Unidades: FMRP, FCFRP
Subjects: CAFEÍNA, ANTI-HISTAMÍNICOS, FÁRMACOS (SISTEMA DIGESTÓRIO), FENÓTIPOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COELHO, Eduardo Barbosa; CUSINATO, Diego Alberto Ciscato; XIMENEZ, João Paulo Bianchi; et al. Limited sampling modeling for estimation of phenotypic metrics for CYP enzymes and the ABCB1 transporter using a cocktail approach. Frontiers in Pharmacology, Lausanne, v. 11, p. 1-7, 2020. Disponível em: < https://doi.org/10.3389/fphar.2020.00022 > DOI: 10.3389/fphar.2020.00022.
APA
Coelho, E. B., Cusinato, D. A. C., Ximenez, J. P. B., Lanchote, V. L., Struchiner, C. J., & Suarez-Kurtz, G. (2020). Limited sampling modeling for estimation of phenotypic metrics for CYP enzymes and the ABCB1 transporter using a cocktail approach. Frontiers in Pharmacology, 11, 1-7. doi:10.3389/fphar.2020.00022
NLM
Coelho EB, Cusinato DAC, Ximenez JPB, Lanchote VL, Struchiner CJ, Suarez-Kurtz G. Limited sampling modeling for estimation of phenotypic metrics for CYP enzymes and the ABCB1 transporter using a cocktail approach [Internet]. Frontiers in Pharmacology. 2020 ; 11 1-7.Available from: https://doi.org/10.3389/fphar.2020.00022
Vancouver
Coelho EB, Cusinato DAC, Ximenez JPB, Lanchote VL, Struchiner CJ, Suarez-Kurtz G. Limited sampling modeling for estimation of phenotypic metrics for CYP enzymes and the ABCB1 transporter using a cocktail approach [Internet]. Frontiers in Pharmacology. 2020 ; 11 1-7.Available from: https://doi.org/10.3389/fphar.2020.00022
Artigo de periodico
Post-marketing assessment of generic tamoxifen in Brazilian breast cancer patients (2020)
Ximenez, João Paulo Bianchi ; Bello, Marcelo A.; Iocken, Fernanda H. S.; Obadia, Renata C. M.; Lanchote, Vera Lucia ; Sousa, Valéria Pereira de; Suarez-Kurtz, Guilherme
Source: Basic Clinical Pharmacology & Toxicology. Unidades: FCFRP, FMRP
Subjects: NEOPLASIAS MAMÁRIAS, QUIMIOTERAPIA, RECEPTORES DE DROGA, ESTRÓGENOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
XIMENEZ, João Paulo Bianchi; BELLO, Marcelo A.; IOCKEN, Fernanda H. S.; et al. Post-marketing assessment of generic tamoxifen in Brazilian breast cancer patients. Basic Clinical Pharmacology & Toxicology, West Sussex, v. 126, n. 5, p. 432-436, 2020. Disponível em: < https://doi.org/10.1111/bcpt.13368 > DOI: 10.1111/bcpt.13368.
APA
Ximenez, J. P. B., Bello, M. A., Iocken, F. H. S., Obadia, R. C. M., Lanchote, V. L., Sousa, V. P. de, & Suarez-Kurtz, G. (2020). Post-marketing assessment of generic tamoxifen in Brazilian breast cancer patients. Basic Clinical Pharmacology & Toxicology, 126( 5), 432-436. doi:10.1111/bcpt.13368
NLM
Ximenez JPB, Bello MA, Iocken FHS, Obadia RCM, Lanchote VL, Sousa VP de, Suarez-Kurtz G. Post-marketing assessment of generic tamoxifen in Brazilian breast cancer patients [Internet]. Basic Clinical Pharmacology & Toxicology. 2020 ; 126( 5): 432-436.Available from: https://doi.org/10.1111/bcpt.13368
Vancouver
Ximenez JPB, Bello MA, Iocken FHS, Obadia RCM, Lanchote VL, Sousa VP de, Suarez-Kurtz G. Post-marketing assessment of generic tamoxifen in Brazilian breast cancer patients [Internet]. Basic Clinical Pharmacology & Toxicology. 2020 ; 126( 5): 432-436.Available from: https://doi.org/10.1111/bcpt.13368
Artigo de periodico
Analysis of daunorubicin and its metabolite daunorubicinol in plasma and urine with application in the evaluation of total, renal and metabolic formation clearances in patients with acute myeloid leukemia (2020)
Oliveira, Milena Locci de ; Rocha, Adriana; Nardotto, Glauco Henrique Balthazar ; Pippa, Leandro Francisco ; Simões, Belinda Pinto ; Lanchote, Vera Lucia
Source: Journal of Pharmaceutical and Biomedical Analysis. Unidades: FCFRP, FMRP
Subjects: LEUCEMIA MIELOIDE AGUDA, ANTINEOPLÁSICOS, METABÓLITOS, FARMACOCINÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, Milena Locci de; ROCHA, Adriana; NARDOTTO, Glauco Henrique Balthazar; et al. Analysis of daunorubicin and its metabolite daunorubicinol in plasma and urine with application in the evaluation of total, renal and metabolic formation clearances in patients with acute myeloid leukemia. Journal of Pharmaceutical and Biomedical Analysis, Amsterdam, v. 191, p. 1-8, 2020. Disponível em: < https://doi.org/10.1016/j.jpba.2020.113576 > DOI: 10.1016/j.jpba.2020.113576.
APA
Oliveira, M. L. de, Rocha, A., Nardotto, G. H. B., Pippa, L. F., Simões, B. P., & Lanchote, V. L. (2020). Analysis of daunorubicin and its metabolite daunorubicinol in plasma and urine with application in the evaluation of total, renal and metabolic formation clearances in patients with acute myeloid leukemia. Journal of Pharmaceutical and Biomedical Analysis, 191, 1-8. doi:10.1016/j.jpba.2020.113576
NLM
Oliveira ML de, Rocha A, Nardotto GHB, Pippa LF, Simões BP, Lanchote VL. Analysis of daunorubicin and its metabolite daunorubicinol in plasma and urine with application in the evaluation of total, renal and metabolic formation clearances in patients with acute myeloid leukemia [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2020 ; 191 1-8.Available from: https://doi.org/10.1016/j.jpba.2020.113576
Vancouver
Oliveira ML de, Rocha A, Nardotto GHB, Pippa LF, Simões BP, Lanchote VL. Analysis of daunorubicin and its metabolite daunorubicinol in plasma and urine with application in the evaluation of total, renal and metabolic formation clearances in patients with acute myeloid leukemia [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2020 ; 191 1-8.Available from: https://doi.org/10.1016/j.jpba.2020.113576
Artigo de periodico
Rheumatoid arthritis downregulates the drug transporter OATP1B1: Fluvastatin as a probe (2020)
Caris, Juciene Aparecida ; Benzi, Jhohann Richard de Lima ; Souza, Flávio Falcão Lima de; Oliveira, Renê Donizeti Ribeiro de; Donadi, Eduardo Antônio ; Lanchote, Vera Lucia
Source: European Journal of Pharmaceutical Sciences. Unidades: FMRP, FCFRP
Subjects: ARTRITE REUMATOIDE, METABOLISMO, ESTUDOS DE CASOS E CONTROLES, CITOCROMO P-450, ESTATINAS, NECROSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARIS, Juciene Aparecida; BENZI, Jhohann Richard de Lima; SOUZA, Flávio Falcão Lima de; et al. Rheumatoid arthritis downregulates the drug transporter OATP1B1: Fluvastatin as a probe. European Journal of Pharmaceutical Sciences, Amsterdam, v. 146, p. 1-7, 2020. Disponível em: < https://doi.org/10.1016/j.ejps.2020.105264 > DOI: 10.1016/j.ejps.2020.105264.
APA
Caris, J. A., Benzi, J. R. de L., Souza, F. F. L. de, Oliveira, R. D. R. de, Donadi, E. A., & Lanchote, V. L. (2020). Rheumatoid arthritis downregulates the drug transporter OATP1B1: Fluvastatin as a probe. European Journal of Pharmaceutical Sciences, 146, 1-7. doi:10.1016/j.ejps.2020.105264
NLM
Caris JA, Benzi JR de L, Souza FFL de, Oliveira RDR de, Donadi EA, Lanchote VL. Rheumatoid arthritis downregulates the drug transporter OATP1B1: Fluvastatin as a probe [Internet]. European Journal of Pharmaceutical Sciences. 2020 ; 146 1-7.Available from: https://doi.org/10.1016/j.ejps.2020.105264
Vancouver
Caris JA, Benzi JR de L, Souza FFL de, Oliveira RDR de, Donadi EA, Lanchote VL. Rheumatoid arthritis downregulates the drug transporter OATP1B1: Fluvastatin as a probe [Internet]. European Journal of Pharmaceutical Sciences. 2020 ; 146 1-7.Available from: https://doi.org/10.1016/j.ejps.2020.105264
Artigo de periodico
Plasma mevalonic acid exposure as a pharmacodynamic biomarker of fluvastatin/atorvastatin in healthy volunteers (2020)
Cestari, Roberta Natália ; Caris, Juciene Aparecida ; Rocha, Adriana; Nardotto, Glauco Henrique Balthazar ; Oliveira, Renê Donizeti Ribeiro de; Lanchote, Vera Lucia
Source: Journal of Pharmaceutical and Biomedical Analysis. Unidades: FCFRP, FMRP
Subjects: ESTATINAS, FARMACOCINÉTICA, FARMACOLOGIA, CROMATOGRAFIA LÍQUIDA DE ALTA PRESSÃO, COMPOSTOS ORGÂNICOS, ESPECTROMETRIA DE MASSAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CESTARI, Roberta Natália; CARIS, Juciene Aparecida; ROCHA, Adriana; et al. Plasma mevalonic acid exposure as a pharmacodynamic biomarker of fluvastatin/atorvastatin in healthy volunteers. Journal of Pharmaceutical and Biomedical Analysis, Amsterdam, v. 182, p. 1-7, 2020. Disponível em: < https://doi.org/10.1016/j.jpba.2020.113128 > DOI: 10.1016/j.jpba.2020.113128.
APA
Cestari, R. N., Caris, J. A., Rocha, A., Nardotto, G. H. B., Oliveira, R. D. R. de, & Lanchote, V. L. (2020). Plasma mevalonic acid exposure as a pharmacodynamic biomarker of fluvastatin/atorvastatin in healthy volunteers. Journal of Pharmaceutical and Biomedical Analysis, 182, 1-7. doi:10.1016/j.jpba.2020.113128
NLM
Cestari RN, Caris JA, Rocha A, Nardotto GHB, Oliveira RDR de, Lanchote VL. Plasma mevalonic acid exposure as a pharmacodynamic biomarker of fluvastatin/atorvastatin in healthy volunteers [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2020 ; 182 1-7.Available from: https://doi.org/10.1016/j.jpba.2020.113128
Vancouver
Cestari RN, Caris JA, Rocha A, Nardotto GHB, Oliveira RDR de, Lanchote VL. Plasma mevalonic acid exposure as a pharmacodynamic biomarker of fluvastatin/atorvastatin in healthy volunteers [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2020 ; 182 1-7.Available from: https://doi.org/10.1016/j.jpba.2020.113128
Artigo de periodico
A background subtraction approach for determination of endogenous cortisol and 6β-hydroxycortisol in urine by UPLC-MS/MS with application in a within-day variability study in HIV-infected pregnant women (2020)
Benzi, Jhohann Richard de Lima ; Moreira, Fernanda de Lima; Marques, Maria Paula ; Duarte, Geraldo; Suarez-Kurtz, Guilherme; Lanchote, Vera Lucia
Source: Journal of Chromatography B. Unidades: FCFRP, FMRP
Subjects: LÍQUIDOS CORPORAIS, CROMATOGRAFIA LÍQUIDA DE ALTA PRESSÃO, CITOCROMO P-450, INFECÇÕES POR HIV, CORTISOL, ESPECTROMETRIA DE MASSAS, FENÓTIPOS, GRAVIDEZ
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BENZI, Jhohann Richard de Lima; MOREIRA, Fernanda de Lima; MARQUES, Maria Paula; et al. A background subtraction approach for determination of endogenous cortisol and 6β-hydroxycortisol in urine by UPLC-MS/MS with application in a within-day variability study in HIV-infected pregnant women. Journal of Chromatography B, Amsterdam, v. 1144 , 2020. Disponível em: < https://doi.org/10.1016/j.jchromb.2020.122074 > DOI: 10.1016/j.jchromb.2020.122074.
APA
Benzi, J. R. de L., Moreira, F. de L., Marques, M. P., Duarte, G., Suarez-Kurtz, G., & Lanchote, V. L. (2020). A background subtraction approach for determination of endogenous cortisol and 6β-hydroxycortisol in urine by UPLC-MS/MS with application in a within-day variability study in HIV-infected pregnant women. Journal of Chromatography B, 1144 . doi:10.1016/j.jchromb.2020.122074
NLM
Benzi JR de L, Moreira F de L, Marques MP, Duarte G, Suarez-Kurtz G, Lanchote VL. A background subtraction approach for determination of endogenous cortisol and 6β-hydroxycortisol in urine by UPLC-MS/MS with application in a within-day variability study in HIV-infected pregnant women [Internet]. Journal of Chromatography B. 2020 ; 1144 Available from: https://doi.org/10.1016/j.jchromb.2020.122074
Vancouver
Benzi JR de L, Moreira F de L, Marques MP, Duarte G, Suarez-Kurtz G, Lanchote VL. A background subtraction approach for determination of endogenous cortisol and 6β-hydroxycortisol in urine by UPLC-MS/MS with application in a within-day variability study in HIV-infected pregnant women [Internet]. Journal of Chromatography B. 2020 ; 1144 Available from: https://doi.org/10.1016/j.jchromb.2020.122074
Artigo de periodico
Chronic Chagas disease with low plasma concentrations of IL-6 does not have a major impact on nebivolol glucuronidation (2020)
Vieira, Carolina Pinto; Neves, Daniel Valente; Nardotto, Glauco Henrique Balthazar; Cesarino, Evandro José ; Rocha, Adriana; Zanardi, Ailton Marcelo Castilho Teno; Lanchote, Vera Lucia
Source: European Journal of Clinical Pharmacology. Unidade: FCFRP
Subjects: BETA-BLOQUEADORES, HIPERTENSÃO, METABOLISMO, IDOSOS, FARMACOCINÉTICA, DOENÇA DE CHAGAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VIEIRA, Carolina Pinto; NEVES, Daniel Valente; NARDOTTO, Glauco Henrique Balthazar; et al. Chronic Chagas disease with low plasma concentrations of IL-6 does not have a major impact on nebivolol glucuronidation. European Journal of Clinical Pharmacology, Heidelberg, v. 76, n. 5, p. 735-737, 2020. Disponível em: < https://doi.org/10.1007/s00228-020-02837-9 > DOI: 10.1007/s00228-020-02837-9.
APA
Vieira, C. P., Neves, D. V., Nardotto, G. H. B., Cesarino, E. J., Rocha, A., Zanardi, A. M. C. T., & Lanchote, V. L. (2020). Chronic Chagas disease with low plasma concentrations of IL-6 does not have a major impact on nebivolol glucuronidation. European Journal of Clinical Pharmacology, 76( 5), 735-737. doi:10.1007/s00228-020-02837-9
NLM
Vieira CP, Neves DV, Nardotto GHB, Cesarino EJ, Rocha A, Zanardi AMCT, Lanchote VL. Chronic Chagas disease with low plasma concentrations of IL-6 does not have a major impact on nebivolol glucuronidation [Internet]. European Journal of Clinical Pharmacology. 2020 ; 76( 5): 735-737.Available from: https://doi.org/10.1007/s00228-020-02837-9
Vancouver
Vieira CP, Neves DV, Nardotto GHB, Cesarino EJ, Rocha A, Zanardi AMCT, Lanchote VL. Chronic Chagas disease with low plasma concentrations of IL-6 does not have a major impact on nebivolol glucuronidation [Internet]. European Journal of Clinical Pharmacology. 2020 ; 76( 5): 735-737.Available from: https://doi.org/10.1007/s00228-020-02837-9
Artigo de periodico
Chiral discrimination of p-glycoprotein in parturient women: effect of fluoxetine on maternal-fetal fexofenadine pharmacokinetics (2020)
Pinto, Leonardo Santos Ribeiro; Moreira, Fernanda de Lima ; Nardotto, Glauco Henrique Balthazar ; Cavalli, Ricardo de Carvalho ; Moisés, Elaine Christine Dantas ; Duarte, Geraldo ; Lanchote, Vera Lucia
Source: Pharmaceutical Research. Unidades: FCFRP, FMRP
Subjects: ESTUDOS DE CASOS E CONTROLES, MUCOSA INTESTINAL, ANTI-HISTAMÍNICOS, ANTIDEPRESSIVOS, FARMACOCINÉTICA, GRAVIDEZ
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PINTO, Leonardo Santos Ribeiro; MOREIRA, Fernanda de Lima; NARDOTTO, Glauco Henrique Balthazar; et al. Chiral discrimination of p-glycoprotein in parturient women: effect of fluoxetine on maternal-fetal fexofenadine pharmacokinetics. Pharmaceutical Research, New York, v. 37, n. 7, 2020. Disponível em: < https://doi.org/10.1007/s11095-020-02854-4 > DOI: 10.1007/s11095-020-02854-4.
APA
Pinto, L. S. R., Moreira, F. de L., Nardotto, G. H. B., Cavalli, R. de C., Moisés, E. C. D., Duarte, G., & Lanchote, V. L. (2020). Chiral discrimination of p-glycoprotein in parturient women: effect of fluoxetine on maternal-fetal fexofenadine pharmacokinetics. Pharmaceutical Research, 37( 7). doi:10.1007/s11095-020-02854-4
NLM
Pinto LSR, Moreira F de L, Nardotto GHB, Cavalli R de C, Moisés ECD, Duarte G, Lanchote VL. Chiral discrimination of p-glycoprotein in parturient women: effect of fluoxetine on maternal-fetal fexofenadine pharmacokinetics [Internet]. Pharmaceutical Research. 2020 ; 37( 7):Available from: https://doi.org/10.1007/s11095-020-02854-4
Vancouver
Pinto LSR, Moreira F de L, Nardotto GHB, Cavalli R de C, Moisés ECD, Duarte G, Lanchote VL. Chiral discrimination of p-glycoprotein in parturient women: effect of fluoxetine on maternal-fetal fexofenadine pharmacokinetics [Internet]. Pharmaceutical Research. 2020 ; 37( 7):Available from: https://doi.org/10.1007/s11095-020-02854-4
Artigo de periodico
A pilot study of the maternal-fetal pharmacokinetics of furosemide in plasma, urine, and amniotic fluid of hypertensive parturient women under cesarean section (2020)
Gonçalves, Paulo Vinícius Bernardes; Moreira, Fernanda de Lima; Benzi, Jhohann Richard de Lima ; Duarte, Geraldo; Lanchote, Vera Lucia
Source: The Journal of Clinical Pharmacology. Unidades: FMRP, FCFRP
Subjects: LÍQUIDO AMNIÓTICO, FÁRMACOS DIURÉTICOS, GRAVIDEZ, TRABALHO DE PARTO INDUZIDO, HIPERTENSÃO NA GRAVIDEZ, CESÁREA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GONÇALVES, Paulo Vinícius Bernardes; MOREIRA, Fernanda de Lima; BENZI, Jhohann Richard de Lima; DUARTE, Geraldo; LANCHOTE, Vera Lucia. A pilot study of the maternal-fetal pharmacokinetics of furosemide in plasma, urine, and amniotic fluid of hypertensive parturient women under cesarean section. The Journal of Clinical Pharmacology, Hoboken, v. 60, n. 12, p. 1655-1661, 2020. Disponível em: < https://doi.org/10.1002/jcph.1681 > DOI: 10.1002/jcph.1681.
APA
Gonçalves, P. V. B., Moreira, F. de L., Benzi, J. R. de L., Duarte, G., & Lanchote, V. L. (2020). A pilot study of the maternal-fetal pharmacokinetics of furosemide in plasma, urine, and amniotic fluid of hypertensive parturient women under cesarean section. The Journal of Clinical Pharmacology, 60( 12), 1655-1661. doi:10.1002/jcph.1681
NLM
Gonçalves PVB, Moreira F de L, Benzi JR de L, Duarte G, Lanchote VL. A pilot study of the maternal-fetal pharmacokinetics of furosemide in plasma, urine, and amniotic fluid of hypertensive parturient women under cesarean section [Internet]. The Journal of Clinical Pharmacology. 2020 ; 60( 12): 1655-1661.Available from: https://doi.org/10.1002/jcph.1681
Vancouver
Gonçalves PVB, Moreira F de L, Benzi JR de L, Duarte G, Lanchote VL. A pilot study of the maternal-fetal pharmacokinetics of furosemide in plasma, urine, and amniotic fluid of hypertensive parturient women under cesarean section [Internet]. The Journal of Clinical Pharmacology. 2020 ; 60( 12): 1655-1661.Available from: https://doi.org/10.1002/jcph.1681
Artigo de periodico
Determination of raltegravir and raltegravir glucuronide in human plasma and urine by LC-MS/MS with application in a maternal-fetal pharmacokinetic study (2020)
Moreira, Fernanda de Lima ; Marques, Maria Paula ; Duarte, Geraldo ; Lanchote, Vera Lucia
Source: Journal of Pharmaceutical and Biomedical Analysis. Unidades: FMRP, FCFRP
Subjects: FÁRMACOS, ANTIRRETROVIRAIS, GRAVIDEZ
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MOREIRA, Fernanda de Lima; MARQUES, Maria Paula; DUARTE, Geraldo; LANCHOTE, Vera Lucia. Determination of raltegravir and raltegravir glucuronide in human plasma and urine by LC-MS/MS with application in a maternal-fetal pharmacokinetic study. Journal of Pharmaceutical and Biomedical Analysis, Amsterdam, v. 177, 2020. Disponível em: < https://doi.org/10.1016/j.jpba.2019.112838 > DOI: 10.1016/j.jpba.2019.112838.
APA
Moreira, F. de L., Marques, M. P., Duarte, G., & Lanchote, V. L. (2020). Determination of raltegravir and raltegravir glucuronide in human plasma and urine by LC-MS/MS with application in a maternal-fetal pharmacokinetic study. Journal of Pharmaceutical and Biomedical Analysis, 177. doi:10.1016/j.jpba.2019.112838
NLM
Moreira F de L, Marques MP, Duarte G, Lanchote VL. Determination of raltegravir and raltegravir glucuronide in human plasma and urine by LC-MS/MS with application in a maternal-fetal pharmacokinetic study [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2020 ; 177Available from: https://doi.org/10.1016/j.jpba.2019.112838
Vancouver
Moreira F de L, Marques MP, Duarte G, Lanchote VL. Determination of raltegravir and raltegravir glucuronide in human plasma and urine by LC-MS/MS with application in a maternal-fetal pharmacokinetic study [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2020 ; 177Available from: https://doi.org/10.1016/j.jpba.2019.112838
Artigo de periodico
Pharmacokinetics and placental transfer of bupivacaine enantiomers in HIV-infected parturient women on antiretroviral therapy (2020)
Souza, Marília Cristina Oliveira ; Pereira, Maria Paula Marques ; Duarte, Geraldo ; Lanchote, Vera Lucia
Source: The Journal of Clinical Pharmacology. Unidades: FCFRP, FMRP
Subjects: ANESTÉSICOS, PARTO, FARMACOCINÉTICA, HIV
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, Marília Cristina Oliveira; PEREIRA, Maria Paula Marques; DUARTE, Geraldo; LANCHOTE, Vera Lucia. Pharmacokinetics and placental transfer of bupivacaine enantiomers in HIV-infected parturient women on antiretroviral therapy. The Journal of Clinical Pharmacology, Hoboken, v. 60, n. 5, p. 566-572, 2020. Disponível em: < https://doi.org/10.1002/jcph.1554 > DOI: 10.1002/jcph.1554.
APA
Souza, M. C. O., Pereira, M. P. M., Duarte, G., & Lanchote, V. L. (2020). Pharmacokinetics and placental transfer of bupivacaine enantiomers in HIV-infected parturient women on antiretroviral therapy. The Journal of Clinical Pharmacology, 60( 5), 566-572. doi:10.1002/jcph.1554
NLM
Souza MCO, Pereira MPM, Duarte G, Lanchote VL. Pharmacokinetics and placental transfer of bupivacaine enantiomers in HIV-infected parturient women on antiretroviral therapy [Internet]. The Journal of Clinical Pharmacology. 2020 ; 60( 5): 566-572.Available from: https://doi.org/10.1002/jcph.1554
Vancouver
Souza MCO, Pereira MPM, Duarte G, Lanchote VL. Pharmacokinetics and placental transfer of bupivacaine enantiomers in HIV-infected parturient women on antiretroviral therapy [Internet]. The Journal of Clinical Pharmacology. 2020 ; 60( 5): 566-572.Available from: https://doi.org/10.1002/jcph.1554

USP Schools

ReP

Filters

Document types

USP Schools

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Publisher

Conference title

Countries/Territories

Funding Agencies

Indexado em

Normalized affiliation

Non normalized affiliation

Countries of institutions of collaboration

Keywords